Advanced Hodgkin's disease: ABVD is better, yet is not good enough!

被引：10

作者：

Diehl, V ^{[1
]}

机构：

[1] Univ Cologne, D-5000 Cologne 41, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 04期

关键词：

D O I：

10.1200/JCO.2003.11.072

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：583 / 585

页数：3

共 23 条

[1] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD
CANELLOS, GP
ANDERSON, JR
PROPERT, KJ
NISSEN, N
COOPER, MR
HENDERSON, ES
GREEN, MR
GOTTLIEB, A
PETERSON, BA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) : 1478 - 1484
[2] Long-term follow-up of Hodgkin's disease trial
Canellos, GP
Niedzwiecki, D
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) : 1417 - 1418
[3] ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial
Chisesi, T
Federico, M
Levis, A
Deliliers, GL
Gobbi, PG
Santini, G
Luminari, S
Brugiatelli, M
[J]. ANNALS OF ONCOLOGY, 2002, 13 : 102 - 106
[4] Treatment of advanced Hodgkin's disease with chemotherapy - Comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada Clinical Trials Group
Connors, JM
Klimo, P
Adams, G
Burns, BF
Cooper, I
Meyer, RM
OReilly, SE
Pater, J
Quirt, I
Sadura, A
Shustik, C
Skillings, J
Sutcliffe, S
Verma, S
Yoshida, S
Zee, B
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1638 - 1645
[5] BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Rueffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duehmke, E
Georgii, A
Loeffler, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3810 - 3821
[6] DIEHL V, 2001, CANC PRINCIPLES PRAC, V2, P2339
[7] Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
Duggan, DB
Petroni, GR
Johnson, JL
Glick, JH
Fisher, RI
Connors, JM
Canellos, GP
Peterson, BA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) : 607 - 614
[8] FEDERICO M, 2002, P AM SOC CLIN ONCOL, V21
[9] MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year results of the Intergroup trial
Glick, JH
Young, ML
Harrington, D
Schilsky, RL
Beck, T
Neiman, R
Fisher, RI
Peterson, BA
Oken, MM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 19 - 26
[10] Hasenclever D, 1996, ANN ONCOL, V7, P95

← 1 2 3 →